Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes

Cardiovascular complications are a common death cause in type 2 diabetes patients, as they are often combined. Plasminogen-activator Inhibitor 1 (PAI-1) participates in the development and progression of cardiovascular complications in diabetes. Insulin resistance increases PAI-1 production, and hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yongzhuo, Li, Wenxuan, Xu, Lili, Wang, Yangang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067678/
https://www.ncbi.nlm.nih.gov/pubmed/37020596
http://dx.doi.org/10.3389/fendo.2023.1124353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067678/
https://www.ncbi.nlm.nih.gov/pubmed/37020596
http://dx.doi.org/10.3389/fendo.2023.1124353

Ejemplares similares